The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders

Kazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Bioactive gaseous molecules, such as oxygen (O2) and carbon monoxide (CO), are essential elements for most living organisms to maintain their homeostasis and biological activities. An accumulating body of evidence suggests that such molecules can be used in clinics as a medical gas in the treatment of various intractable disorders. Recent developments in hemoglobin-encapsulated liposomes, namely hemoglobin vesicles (HbV), possess great potential for retaining O2 and CO and could lead to strategies for the development of novel pharmacological agents as medical gas donors. HbV with either O2 or CO bound to it has been demonstrated to have therapeutic potential for treating certain intractable disorders and has the possibility to serve as diagnostic and augmenting product by virtue of unique physicochemical characteristics of HbV. The present review provides an overview of the present status of the use of O2- or CO-binding HbV in experimental animal models of intractable disorders and discusses prospective clinical applications of HbV as a medical gas donor.

Original languageEnglish
Pages (from-to)2392-2400
Number of pages9
JournalJournal of Pharmaceutical Sciences
Volume106
Issue number9
DOIs
Publication statusPublished - 2017 Sep 1
Externally publishedYes

Fingerprint

Hemoglobins
Gases
Carbon Monoxide
Therapeutics
Liposomes
Homeostasis
Animal Models
Pharmacology
Oxygen

Keywords

  • biomimetics
  • controlled release
  • liposomes
  • nanotechnology
  • particle size

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. / Taguchi, Kazuaki; Yamasaki, Keishi; Sakai, Hiromi; Maruyama, Toru; Otagiri, Masaki.

In: Journal of Pharmaceutical Sciences, Vol. 106, No. 9, 01.09.2017, p. 2392-2400.

Research output: Contribution to journalReview article

Taguchi, Kazuaki ; Yamasaki, Keishi ; Sakai, Hiromi ; Maruyama, Toru ; Otagiri, Masaki. / The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. In: Journal of Pharmaceutical Sciences. 2017 ; Vol. 106, No. 9. pp. 2392-2400.
@article{9e9748f4863f4bd2801ba616a3e7748c,
title = "The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders",
abstract = "Bioactive gaseous molecules, such as oxygen (O2) and carbon monoxide (CO), are essential elements for most living organisms to maintain their homeostasis and biological activities. An accumulating body of evidence suggests that such molecules can be used in clinics as a medical gas in the treatment of various intractable disorders. Recent developments in hemoglobin-encapsulated liposomes, namely hemoglobin vesicles (HbV), possess great potential for retaining O2 and CO and could lead to strategies for the development of novel pharmacological agents as medical gas donors. HbV with either O2 or CO bound to it has been demonstrated to have therapeutic potential for treating certain intractable disorders and has the possibility to serve as diagnostic and augmenting product by virtue of unique physicochemical characteristics of HbV. The present review provides an overview of the present status of the use of O2- or CO-binding HbV in experimental animal models of intractable disorders and discusses prospective clinical applications of HbV as a medical gas donor.",
keywords = "biomimetics, controlled release, liposomes, nanotechnology, particle size",
author = "Kazuaki Taguchi and Keishi Yamasaki and Hiromi Sakai and Toru Maruyama and Masaki Otagiri",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.xphs.2017.04.006",
language = "English",
volume = "106",
pages = "2392--2400",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders

AU - Taguchi, Kazuaki

AU - Yamasaki, Keishi

AU - Sakai, Hiromi

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Bioactive gaseous molecules, such as oxygen (O2) and carbon monoxide (CO), are essential elements for most living organisms to maintain their homeostasis and biological activities. An accumulating body of evidence suggests that such molecules can be used in clinics as a medical gas in the treatment of various intractable disorders. Recent developments in hemoglobin-encapsulated liposomes, namely hemoglobin vesicles (HbV), possess great potential for retaining O2 and CO and could lead to strategies for the development of novel pharmacological agents as medical gas donors. HbV with either O2 or CO bound to it has been demonstrated to have therapeutic potential for treating certain intractable disorders and has the possibility to serve as diagnostic and augmenting product by virtue of unique physicochemical characteristics of HbV. The present review provides an overview of the present status of the use of O2- or CO-binding HbV in experimental animal models of intractable disorders and discusses prospective clinical applications of HbV as a medical gas donor.

AB - Bioactive gaseous molecules, such as oxygen (O2) and carbon monoxide (CO), are essential elements for most living organisms to maintain their homeostasis and biological activities. An accumulating body of evidence suggests that such molecules can be used in clinics as a medical gas in the treatment of various intractable disorders. Recent developments in hemoglobin-encapsulated liposomes, namely hemoglobin vesicles (HbV), possess great potential for retaining O2 and CO and could lead to strategies for the development of novel pharmacological agents as medical gas donors. HbV with either O2 or CO bound to it has been demonstrated to have therapeutic potential for treating certain intractable disorders and has the possibility to serve as diagnostic and augmenting product by virtue of unique physicochemical characteristics of HbV. The present review provides an overview of the present status of the use of O2- or CO-binding HbV in experimental animal models of intractable disorders and discusses prospective clinical applications of HbV as a medical gas donor.

KW - biomimetics

KW - controlled release

KW - liposomes

KW - nanotechnology

KW - particle size

UR - http://www.scopus.com/inward/record.url?scp=85019902111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019902111&partnerID=8YFLogxK

U2 - 10.1016/j.xphs.2017.04.006

DO - 10.1016/j.xphs.2017.04.006

M3 - Review article

C2 - 28414143

AN - SCOPUS:85019902111

VL - 106

SP - 2392

EP - 2400

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 9

ER -